Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus helveticus Rosell-52 and Improved Mental Health

Research synthesisVery low evidenceSmall effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies (all reviews from 2022–2025), all reported small beneficial effects of Lactobacillus helveticus Rosell-52 on mental health outcomes. However, none of the included studies provided statistical significance testing for this specific supplement-outcome pair, and no consistent dose, form, or duration data were extractable. The evidence base is very small and entirely review-level, making the aggregate finding preliminary.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. All three studies are narrative reviews rather than primary clinical trials; no original data specific to Lactobacillus helveticus Rosell-52 for mental health were directly reported. Statistically significant results were not consistently present across the underlying studies reviewed. Available evidence is overwhelmingly positive in direction — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed).

Generated Jun 11, 2026
3 of 3 papers
Back to top